Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v8-EN
Language French English
Date Updated 2021-08-04 2021-07-13
Drug Identification Number 02415186 02415186
Brand name TARO-ZOLEDRONIC ACID CONCENTRATE TARO-ZOLEDRONIC ACID CONCENTRATE
Common or Proper name ZOLEDRONIC ACID ZOLEDRONIC ACID
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients ZOLEDRONIC ACID ZOLEDRONIC ACID
Strength(s) 4MG 4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 5 ml 5 ml
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-20 2021-04-20
Estimated end date 2021-07-30 2021-07-23
Actual end date 2021-07-23
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments